Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3439521, 10 pages
http://dx.doi.org/10.1155/2016/3439521
Research Article

Significant Modules and Biological Processes between Active Components of Salvia miltiorrhiza Depside Salt and Aspirin

1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, No. 16 Nanxiao Street, Dongzhimennei, Dongcheng District, Beijing 100700, China
2Department of Epidemiology, University of California, Los Angeles, 405 Hilgard Avenue, CA 90095, USA

Received 16 October 2015; Revised 8 December 2015; Accepted 12 January 2016

Academic Editor: Helmut Hugel

Copyright © 2016 Yuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Holbrook, S. Schulman, D. M. Witt et al., “Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, no. 2, supplement, pp. e152S–e184S, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Morita, “Distinct functions of COX-1 and COX-2,” Prostaglandins and Other Lipid Mediators, vol. 68-69, pp. 165–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. H. D. Lewis Jr., J. W. Davis, D. G. Archibald et al., “Protective effects of aspirin against acute myocardial infarction and death in mean with unstable angina. Results of a veterans administration cooperative study,” New England Journal of Medicine, vol. 309, no. 7, pp. 396–403, 1983. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. Julian, D. A. Chamberlain, and S. J. Pocock, “A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial,” British Medical Journal, vol. 313, no. 7070, pp. 1429–1431, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Zhou, Z. Zuo, and M. S. S. Chow, “Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use,” Journal of Clinical Pharmacology, vol. 45, no. 12, pp. 1345–1359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Watzke, S. J. O'Malley, R. G. Bergman, and J. A. Ellman, “Reassignment of the configuration of salvianolic acid B and establishment of its identity with lithospermic acid B,” Journal of Natural Products, vol. 69, no. 8, pp. 1231–1233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Zhang, A.-D. Liu, and Y.-S. Huang, “Clinical non-inferiority trial on treatment of coronary heart disease angina pectoris of Xin-blood stasis syndrome type with lyophilized Salvia salt of lithospermic acid powder for injection,” Chinese Journal of Integrative Medicine, vol. 12, no. 1, pp. 12–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Hopkins, “Network pharmacology,” Nature Biotechnology, vol. 25, no. 10, pp. 1110–1111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Hopkins, “Network pharmacology: the next paradigm in drug discovery,” Nature Chemical Biology, vol. 4, no. 11, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Safran, I. Dalah, J. Alexander et al., “GeneCards Version 3: the human gene integrator,” Database, vol. 2010, Article ID baq020, 2010. View at Google Scholar · View at Scopus
  11. M. Shklar, L. Strichman-Almashanu, O. Shmueli, M. Shmoish, M. Safran, and D. Lancet, “GeneTide—Terra Incognita Discovery Endeavor: a new transcriptome focused member of the GeneCards/GeneNote suite of databases,” Nucleic Acids Research, vol. 33, supplement 1, pp. D556–D561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Kuhn, D. Szklarczyk, A. Franceschini et al., “STITCH 2: an interaction network database for small molecules and proteins,” Nucleic Acids Research, vol. 38, pp. D552–D556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kuhn, D. Szklarczyk, S. Pletscher-Frankild et al., “STITCH 4: integration of protein-chemical interactions with user data,” Nucleic Acids Research, vol. 42, no. 1, pp. D401–D407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Su, J. H. Morris, B. Demchak, and G. D. Bader, “Biological network exploration with cytoscape 3,” Current Protocols in Bioinformatics, vol. 47, pp. 8–13, 2014. View at Google Scholar
  15. C. G. Rivera, R. Vakil, and J. S. Bader, “NeMo: network module identification in cytoscape,” BMC Bioinformatics, vol. 11, supplement 1, article S61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. R. Burkard, U. Rix, F. P. Breitwieser, G. Superti-Furga, and J. Colinge, “A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib,” PLoS Computational Biology, vol. 6, no. 11, Article ID e1001001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Folkman, “Angiogenesis and c-Jun,” Journal of the National Cancer Institute, vol. 96, no. 9, p. 644, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Pedram, M. Razandi, and E. R. Levin, “Extracellular signal-regulated protein kinase/jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation,” The Journal of Biological Chemistry, vol. 273, no. 41, pp. 26722–26728, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-C. Tille and M. S. Pepper, “Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro,” Experimental Cell Research, vol. 280, no. 2, pp. 179–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Benckert, S. Jonas, T. Cramer et al., “Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells,” Cancer Research, vol. 63, no. 5, pp. 1083–1092, 2003. View at Google Scholar · View at Scopus
  21. E. Galkina and K. Ley, “Vascular adhesion molecules in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 11, pp. 2292–2301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. D. O'Brien, T. O. McDonald, A. Chait, M. D. Allen, and C. E. Alpers, “Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content,” Circulation, vol. 93, no. 4, pp. 672–682, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. L. S. A. Capettini, S. F. Cortes, J. F. Silva, J. I. Alvarez-Leite, and V. S. Lemos, “Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis,” British Journal of Pharmacology, vol. 164, no. 6, pp. 1738–1748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Li and U. Förstermann, “Prevention of atherosclerosis by interference with the vascular nitric oxide system,” Current Pharmaceutical Design, vol. 15, no. 27, pp. 3133–3145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Zhang, J. Yuan, M. Yu et al., “IL-17A facilitates platelet function through the ERK2 signaling pathway in patients with acute coronary syndrome,” PLoS ONE, vol. 7, no. 7, Article ID e40641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. E. Nassef, M. A. Hamed, and H. F. Aly, “Inflammatory cytokines, apoptotic, tissue injury and remodeling biomarkers in children with congenital heart disease,” Indian Journal of Clinical Biochemistry, vol. 29, no. 2, pp. 145–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Wang, G.-B. Sun, X. Sun et al., “Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway,” Toxicology Letters, vol. 216, no. 2-3, pp. 100–107, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. W.-H. Fan and M. J. Karnovsky, “Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 277, no. 12, pp. 9800–9805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. N. V. O. Sweeney, P. M. Cummins, Y. A. Birney, E. M. Redmond, and P. A. Cahill, “Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration,” Biochemical and Biophysical Research Communications, vol. 320, no. 2, pp. 325–333, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Lévy, C. Maurey, D. S. Celermajer et al., “Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease,” Journal of the American College of Cardiology, vol. 49, no. 7, pp. 803–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. Ú. Catalán, S. Fernández-Castillejo, L. Pons et al., “Alpha-tocopherol and BAY 11-7082 reduce vascular cell adhesion molecule in human aortic endothelial cells,” Journal of Vascular Research, vol. 49, no. 4, pp. 319–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Eleftheriadis, G. Antoniadi, V. Liakopoulos, G. Pissas, I. Stefanidis, and G. Galaktidou, “Plasma angiogenin and vascular endothelial growth factor a among hemodialysis patients,” Iranian Journal of Kidney Diseases, vol. 6, no. 3, pp. 209–215, 2012. View at Google Scholar · View at Scopus
  33. S. Cagnin, M. Biscuola, C. Patuzzo et al., “Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries,” BMC Genomics, vol. 10, article no. 13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. C. Chen, Y. L. Lin, B. Huang, D. L. Wang, and J. J. Cheng, “Salvianolic acid B suppresses IFN-γ-induced JAK/STAT1 activation in endothelial cells,” Thrombosis Research, vol. 128, no. 6, pp. 560–564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. H. Bredie, H. Wollersheim, F. W. A. Verheugt, and T. Thien, “Low-dose aspirin for primary prevention of cardiovascular disease,” Seminars in Vascular Medicine, vol. 3, no. 2, pp. 177–184, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Wilson, J. Gazzala, and J. House, “Aspirin in primary and secondary prevention in elderly adults revisited,” Southern Medical Journal, vol. 105, no. 2, pp. 82–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. A. Khan, A. Ali, S. A. Khan et al., “Unraveling the complex relationship triad between lipids, obesity, and inflammation,” Mediators of Inflammation, vol. 2014, Article ID 502749, 16 pages, 2014. View at Publisher · View at Google Scholar
  38. M. Laakso and J. Kuusisto, “Insulin resistance and hyperglycaemia in cardiovascular disease development,” Nature Reviews Endocrinology, vol. 10, no. 5, pp. 293–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. G. S. Hotamisligil, “Endoplasmic reticulum stress and the inflammatory basis of metabolic disease,” Cell, vol. 140, no. 6, pp. 900–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Tjokroprawiro, “New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer),” Acta Medica Indonesiana, vol. 38, no. 3, pp. 160–166, 2006. View at Google Scholar · View at Scopus
  41. K. Y. Hur, H. J. Seo, E. S. Kang et al., “Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury,” European Journal of Pharmacology, vol. 586, no. 1–3, pp. 226–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. X.-J. Wu, Y.-P. Wang, W. Wang, W.-K. Sun, Y.-M. Xu, and L.-J. Xuan, “Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B,” Acta Pharmacologica Sinica, vol. 21, no. 9, pp. 855–858, 2000. View at Google Scholar · View at Scopus
  43. J. Ba, H. Peng, Y. Chen, and Y. Gao, “Effects and mechanism analysis of vascular endothelial growth factor and salvianolic acid B on 125I-low density lipoprotein permeability of the rabbit aortary endothelial cells,” Cell Biochemistry and Biophysics, vol. 70, no. 3, pp. 1533–1538, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Joe, M. Zheng, H. J. Kim et al., “Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities,” Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 3, pp. 850–858, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. T.-L. Yang, F.-Y. Lin, Y.-H. Chen et al., “Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits,” Journal of the Science of Food and Agriculture, vol. 91, no. 1, pp. 134–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-H. Chen, G.-H. Du, and J.-T. Zhang, “Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats,” Acta Pharmacologica Sinica, vol. 21, no. 5, pp. 463–466, 2000. View at Google Scholar · View at Scopus